Literature DB >> 21619052

Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects.

Khalid Muzaffar Banday1, Kishore Kumar Pasikanti, Eric Chun Yong Chan, Rupak Singla, Kanury Venkata Subba Rao, Virander Singh Chauhan, Ranjan Kumar Nanda.   

Abstract

Development of noninvasive methods for tuberculosis (TB) diagnosis, with the potential to be administered in field situations, remains as an unmet challenge. A wide array of molecules are present in urine and reflect the pathophysiological condition of a subject. With infection, an alteration in the molecular constituents is anticipated, characterization of which may form a basis for TB diagnosis. In the present study volatile organic compounds (VOCs) in human urine derived from TB patients and healthy controls were identified and quantified using headspace gas chromatography/mass spectrometry (GC/MS). We found significant (p < 0.05) increase in the abundance of o-xylene (6.37) and isopropyl acetate (2.07) and decreased level of 3-pentanol (0.59), dimethylstyrene (0.37), and cymol (0.42) in TB patients compared to controls. These markers could discriminate TB from healthy controls and related diseases like lung cancer and chronic obstructive pulmonary disorder. This study suggests a possibility of using urinary VOCs for the diagnosis of human TB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619052     DOI: 10.1021/ac200265g

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  27 in total

1.  Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Xibei Jia; Ruichan Liu
Journal:  Med Princ Pract       Date:  2017-06-19       Impact factor: 1.927

2.  True facets of TB diagnosis in 2012: Hypes and realities.

Authors:  S K Parida
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-12-11

3.  First report of disseminated Mycobacterium skin infections in two liver transplant recipients and rapid diagnosis by hsp65 gene sequencing.

Authors:  Susanna K P Lau; Shirly O T Curreem; Antonio H Y Ngan; Chi-Keung Yeung; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

4.  Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.

Authors:  Susanna K P Lau; Kim-Chung Lee; Shirly O T Curreem; Wang-Ngai Chow; Kelvin K W To; Ivan F N Hung; Deborah T Y Ho; Siddharth Sridhar; Iris W S Li; Vanessa S Y Ding; Eleanor W F Koo; Chi-Fong Wong; Sidney Tam; Ching-Wan Lam; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2015-09-16       Impact factor: 5.948

Review 5.  Clinical application of volatile organic compound analysis for detecting infectious diseases.

Authors:  Shneh Sethi; Ranjan Nanda; Trinad Chakraborty
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Rapid Diagnosis of Tuberculosis from Analysis of Urine Volatile Organic Compounds.

Authors:  Sung H Lim; Raymond Martino; Victoria Anikst; Zeyu Xu; Samantha Mix; Robert Benjamin; Herbert Schub; Michael Eiden; Paul A Rhodes; Niaz Banaei
Journal:  ACS Sens       Date:  2016-06-09       Impact factor: 7.711

7.  Global Urine Metabolomics in Patients Treated with First-Line Tuberculosis Drugs and Identification of a Novel Metabolite of Ethambutol.

Authors:  Mrinal Kumar Das; Rakesh Arya; Sanjita Debnath; Rahul Debnath; Anindita Lodh; Subasa Chandra Bishwal; Anjan Das; Ranjan Kumar Nanda
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 8.  Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

Authors:  Payam Nahid; Peter S Kim; Carlton A Evans; David Alland; Michael Barer; Jane Diefenbach; Jerrold Ellner; Richard Hafner; Carol Dukes Hamilton; Michael F Iademarco; Gregory Ireton; Michael E Kimerling; Christian Lienhardt; William R MacKenzie; Megan Murray; Mark D Perkins; Jamie E Posey; Teri Roberts; Christine Sizemore; Wendy S Stevens; Laura Via; Sharon D Williams; Wing W Yew; Susan Swindells
Journal:  J Infect Dis       Date:  2012-04-03       Impact factor: 5.226

Review 9.  Diagnosis & treatment of tuberculosis in HIV co-infected patients.

Authors:  C Padmapriyadarsini; G Narendran; Soumya Swaminathan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

10.  Urine as a specimen to diagnose infections in twenty-first century: focus on analytical accuracy.

Authors:  Tamara Tuuminen
Journal:  Front Immunol       Date:  2012-03-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.